{ "items": [ "\n\n
The PICRAM study is funded by the Health Innovation Challenge Fund, a joint initiative supported by the Department of Health and the Wellcome Trust.
\n \n\n \n \nThe Critical care Atrial Fibrillation Evaluation (CAFE) study bought together the best evidence on which to base improved guidelines for treatment of patients who develop new-onset atrial fibrillation on an ICU.
\n \n\n \n \nThe Renal Replacement Anticoagulant Management (RRAM) study will research the advantages and disadvantages of the two anticoagulant methods for patients with a kidney injury and treated in an ICU
\n \n\n \n \nThe Sleep in the Intensive Care Unit: Lowering Elements of Noise in the Critical Care Environment (SILENCE) research programme was funded by a feasibility study grant awarded by the NIHR Research for Patient Benefit scheme, and was sponsored by the University of Oxford. \r\n\r\nFor all enquires about the SILENCE project please email: silence@ndcn.ox.ac.uk\r\n\r\nThe project ended in 2018 and results from the study have been published. See details below.
\n \n\n \n \nThe PARADISE study is an international collaboration that will develop two reliable prediction models to identify which patients are at greatest risk of developing Atrial Fibrillation (AF) following heart surgery.
\n \n\n \n \nThe FOBS study aims to develop an evidence-based protocol for how frequently observations should be made that will be both safe and achievable across all acute NHS hospitals
\n \n\n \n \nThe non-contact vital signs monitoring (NVSM) study was a joint collaboration between the Department of Engineering, the Nuffield Department of Clinical Neurosciences, and Oxehealth Ltd.
\n \n\n \n \n